Fonar - 32 Year Stock Price History | FONR
Historical daily share price chart and data for Fonar since 1993 adjusted for splits and dividends. The latest closing stock price for Fonar as of January 17, 2025 is 15.22.
- The all-time high Fonar stock closing price was 112.50 on March 13, 2000.
- The Fonar 52-week high stock price is 24.05, which is 58% above the current share price.
- The Fonar 52-week low stock price is 14.05, which is 7.7% below the current share price.
- The average Fonar stock price for the last 52 weeks is 17.27.
| Fonar Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2025 | 15.2073 | 15.1000 | 15.4000 | 15.0200 | 15.2200 | 0.53% |
| 2024 | 17.4810 | 20.1000 | 23.2400 | 14.3900 | 15.1400 | -22.60% |
| 2023 | 16.7750 | 16.8500 | 20.5000 | 12.5200 | 19.5600 | 16.78% |
| 2022 | 16.2372 | 15.0500 | 19.1000 | 13.3100 | 16.7500 | 11.82% |
| 2021 | 17.4227 | 18.3200 | 20.3500 | 14.5500 | 14.9800 | -13.71% |
| 2020 | 20.6611 | 20.1900 | 26.4900 | 11.2100 | 17.3600 | -11.83% |
| 2019 | 21.2884 | 21.2500 | 25.0700 | 19.2000 | 19.6900 | -2.72% |
| 2018 | 25.3970 | 24.3500 | 29.8000 | 20.0700 | 20.2400 | -16.88% |
| 2017 | 24.4442 | 19.2250 | 33.6000 | 17.4500 | 24.3500 | 27.15% |
| 2016 | 18.1649 | 16.7800 | 23.7800 | 13.3200 | 19.1500 | 10.95% |
| 2015 | 12.5383 | 10.2600 | 18.3300 | 9.1300 | 17.2600 | 65.96% |
| 2014 | 14.4647 | 20.1700 | 26.3200 | 9.6700 | 10.4000 | -50.96% |
| 2013 | 8.0377 | 4.6000 | 21.2080 | 4.5900 | 21.2080 | 389.79% |
| 2012 | 3.6961 | 1.7300 | 6.4000 | 1.6900 | 4.3300 | 154.11% |
| 2011 | 1.8012 | 1.3000 | 2.6500 | 1.2600 | 1.7040 | 31.08% |
| 2010 | 1.4940 | 1.7000 | 2.7200 | 1.0200 | 1.3000 | -17.20% |
| 2009 | 1.6153 | 0.9200 | 3.1900 | 0.6305 | 1.5700 | 89.16% |
| 2008 | 2.4096 | 5.3200 | 5.3200 | 0.6651 | 0.8300 | -84.04% |
| 2007 | 6.4569 | 7.5000 | 8.1400 | 4.2080 | 5.2000 | -25.71% |
| 2006 | 12.2490 | 17.7500 | 20.5000 | 6.2500 | 7.0000 | -58.82% |
| 2005 | 29.9603 | 39.2500 | 43.0000 | 17.0000 | 17.0000 | -56.69% |
| 2004 | 32.0387 | 29.0000 | 42.7500 | 25.5000 | 39.2500 | 36.52% |
| 2003 | 30.8125 | 26.7500 | 49.5000 | 20.2500 | 28.7500 | 7.48% |
| 2002 | 30.6647 | 30.5000 | 50.2500 | 24.2500 | 26.7500 | -10.08% |
| 2001 | 37.9819 | 32.7500 | 62.2500 | 25.7500 | 29.7500 | -9.16% |
| 2000 | 57.9931 | 46.7500 | 112.5000 | 28.0000 | 32.7500 | -22.49% |
| 1999 | 31.2716 | 35.0538 | 75.0000 | 18.7500 | 42.2500 | 35.96% |
| 1998 | 50.5701 | 68.5234 | 73.8883 | 26.1990 | 31.0761 | -56.65% |
| 1997 | 69.5490 | 54.8675 | 96.8107 | 52.6728 | 71.6936 | 25.64% |
| 1996 | 60.0365 | 64.8656 | 73.8883 | 51.6974 | 57.0622 | -12.03% |
| 1995 | 66.3674 | 46.5764 | 97.5423 | 40.4800 | 64.8656 | 33.00% |
| 1994 | 42.2809 | 52.6728 | 62.4270 | 30.4820 | 48.7711 | -7.41% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.096B | $0.103B |
| FONAR Corporation is a developer and manufacturer of MRI scanners. The Company has introduced the world's first commercial MRI in 1980, and went public in 1981. FONAR's stellar product is the UPRIGHT MRI, also known as the Stand-Up MRI, the whole-body MRI that performs Position imaging and scans patients in numerous weight-bearing positions like standing, sitting, in flexion and extension, as well as the conventional lie-down position. The Company's subsidiary, Health Management Corporation of America, is a physician practice management company providing management services to medical providers. FONAR Corporation is based in Melville, New York. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $196.826B | 25.11 |
| Stryker (SYK) | United States | $146.166B | 32.94 |
| Boston Scientific (BSX) | United States | $145.408B | 41.81 |
| EssilorLuxottica (ESLOY) | France | $115.383B | 0.00 |
| Medtronic (MDT) | Ireland | $112.944B | 16.78 |
| Lonza Group Ag (LZAGY) | Switzerland | $43.849B | 0.00 |
| Haleon (HLN) | United Kingdom | $41.827B | 27.18 |
| GE HealthCare Technologies (GEHC) | United States | $38.715B | 20.08 |
| ResMed (RMD) | United States | $35.199B | 28.92 |
| Terumo (TRUMY) | Japan | $27.980B | 0.00 |
| Koninklijke Philips (PHG) | Netherlands | $24.250B | 18.56 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.811B | 13.89 |
| Insulet (PODD) | United States | $19.347B | 77.04 |
| Baxter (BAX) | United States | $15.818B | 10.29 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.057B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $9.586B | 32.58 |
| BellRing Brands (BRBR) | United States | $9.323B | 37.51 |
| Demant (WILYY) | Denmark | $8.735B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.360B | 14.78 |
| ICU Medical (ICUI) | United States | $4.012B | 38.20 |
| Prestige Consumer Healthcare (PBH) | United States | $3.882B | 19.31 |
| Haemonetics (HAE) | United States | $3.691B | 18.01 |
| Envista Holdings (NVST) | United States | $3.413B | 25.42 |
| Perrigo (PRGO) | Ireland | $3.252B | 9.57 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.010B | 0.00 |
| QuidelOrtho (QDEL) | United States | $2.807B | 18.07 |
| GN Store Nord (GNNDY) | Denmark | $2.585B | 16.58 |
| Neogen (NEOG) | United States | $2.508B | 28.90 |
| LeMaitre Vascular (LMAT) | United States | $2.227B | 54.13 |
| AtriCure (ATRC) | United States | $1.876B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.572B | 27.52 |
| AdaptHealth (AHCO) | United States | $1.416B | 10.11 |
| InMode (INMD) | Israel | $1.410B | 8.48 |
| BioLife Solutions (BLFS) | United States | $1.213B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.205B | 0.00 |
| Owens & Minor (OMI) | United States | $1.124B | 8.78 |
| Curaleaf Holdings (CURLF) | Canada | $0.981B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.843B | 14.87 |
| CeriBell (CBLL) | United States | $0.754B | 0.00 |
| Evolus (EOLS) | United States | $0.666B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.623B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.557B | 24.58 |
| Omeros (OMER) | United States | $0.541B | 0.00 |
| Surmodics (SRDX) | United States | $0.527B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.434B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.434B | 0.00 |
| ZimVie (ZIMV) | United States | $0.394B | 33.23 |
| Valneva SE (VALN) | France | $0.355B | 0.00 |
| Quanterix (QTRX) | United States | $0.342B | 0.00 |
| Cerus (CERS) | United States | $0.332B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.317B | 30.18 |
| Biote (BTMD) | United States | $0.306B | 6.71 |
| Sanara MedTech (SMTI) | United States | $0.285B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.272B | 18.25 |
| High Tide (HITI) | Canada | $0.250B | 103.00 |
| Zynex (ZYXI) | United States | $0.245B | 51.20 |
| Canopy Growth (CGC) | Canada | $0.237B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.226B | 3.18 |
| Aurora Cannabis (ACB) | Canada | $0.211B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.211B | 14.56 |
| Organigram Holdings (OGI) | Canada | $0.196B | 0.00 |
| Brainsway (BWAY) | Israel | $0.192B | 102.30 |
| MacroGenics (MGNX) | United States | $0.188B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.168B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.150B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.149B | 18.77 |
| Veru (VERU) | United States | $0.143B | 0.00 |
| Jin Medical (ZJYL) | China | $0.143B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.130B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.092B | 0.00 |
| INLIF (INLF) | $0.078B | 0.00 | |
| InterCure (INCR) | Israel | $0.077B | 0.00 |
| Exagen (XGN) | United States | $0.070B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.069B | 35.33 |
| Jushi Holdings (JUSHF) | United States | $0.063B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.058B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.056B | 0.00 |
| Apyx Medical (APYX) | United States | $0.052B | 0.00 |
| ImmuCell (ICCC) | United States | $0.049B | 0.00 |
| Modular Medical (MODD) | United States | $0.042B | 0.00 |
| Safety Shot (SHOT) | United States | $0.033B | 0.00 |
| Nephros (NEPH) | United States | $0.017B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.008B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.008B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.006B | 0.00 |
| Agape ATP (ATPC) | $0.005B | 0.00 | |
| IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
| Sharps Technology (STSS) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.001B | 0.00 |
| United-Guardian (UG) | United States | $0.000B | 14.11 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |